Income Statement (TTM)
PYC Therapeutics Limited Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2 | 2 | 3 | 3 | 6 | 9 | 13 | 16 | 15 | 14 | 15 | 16 | 19 | 21 | 22 | 22 | 24 | 25 | 24 | 23 |
| Change (%) | 0.00 | 14.16 | 12.41 | 97.49 | 49.36 | 38.45 | 27.77 | -7.86 | -8.53 | 8.45 | 7.79 | 17.19 | 14.67 | 1.93 | 1.89 | 6.64 | 6.23 | -2.99 | -3.08 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | -1 | -1 | -1 | |||||||||||||||||
| Change (%) | 105.05 | -50.00 | ||||||||||||||||||
| % of Revenue | -25.73 | -52.77 | -23.11 | |||||||||||||||||
| Gross Operating Profit | 3 | 4 | 3 | 3 | 6 | 9 | 13 | 16 | 15 | 14 | 15 | 16 | 19 | 21 | 22 | 22 | 24 | 25 | 24 | 23 |
| Change (%) | 21.50 | -8.00 | -8.69 | 97.49 | 49.36 | 38.45 | 27.77 | -7.86 | -8.53 | 8.45 | 7.79 | 17.19 | 14.67 | 1.93 | 1.89 | 6.64 | 6.23 | -2.99 | -3.08 | |
| % of Revenue | 125.73 | 152.77 | 123.11 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| SG&A | 4 | 4 | 6 | 8 | 8 | 8 | 7 | 6 | 6 | 6 | 5 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 6 | 7 |
| Change (%) | 3.45 | 45.55 | 31.29 | 2.43 | 2.37 | -11.64 | -13.18 | -5.69 | -6.03 | -13.35 | -15.41 | 0.32 | 0.32 | 4.75 | 4.53 | 3.59 | 3.47 | 23.16 | 18.81 | |
| % of Revenue | 165.32 | 171.02 | 218.03 | 254.66 | 132.08 | 90.53 | 57.77 | 39.26 | 40.18 | 41.28 | 32.98 | 25.88 | 22.16 | 19.38 | 19.92 | 20.44 | 19.85 | 19.34 | 24.55 | 30.09 |
| R&D | 8 | 11 | 12 | 14 | 16 | 18 | 21 | 24 | 28 | 33 | 34 | 35 | 37 | 39 | 48 | 56 | 63 | 70 | 70 | 70 |
| Change (%) | 30.10 | 14.34 | 12.54 | 15.53 | 13.44 | 15.47 | 13.40 | 17.82 | 15.12 | 3.91 | 3.77 | 5.55 | 5.26 | 22.23 | 18.19 | 12.29 | 10.94 | -0.16 | -0.16 | |
| % of Revenue | 349.14 | 454.23 | 454.95 | 455.50 | 266.45 | 202.36 | 168.78 | 149.79 | 191.54 | 241.08 | 230.99 | 222.36 | 200.26 | 183.82 | 220.44 | 255.71 | 269.25 | 281.21 | 289.43 | 298.16 |
| OpEx | 12 | 13 | 18 | 22 | 24 | 26 | 28 | 30 | 34 | 38 | 39 | 39 | 41 | 43 | 52 | 61 | 68 | 75 | 76 | 77 |
| Change (%) | 15.80 | 31.82 | 24.14 | 10.67 | 9.64 | 7.24 | 6.75 | 13.05 | 11.55 | 1.30 | 1.28 | 5.00 | 4.76 | 20.57 | 17.06 | 11.64 | 10.43 | 1.34 | 1.33 | |
| % of Revenue | 480.95 | 556.94 | 643.05 | 710.16 | 397.96 | 292.12 | 226.27 | 189.05 | 231.96 | 282.88 | 264.21 | 248.24 | 222.42 | 203.20 | 240.36 | 276.15 | 289.11 | 300.55 | 313.98 | 328.26 |
| Operating Income | -9 | -11 | -15 | -19 | -18 | -17 | -16 | -14 | -20 | -25 | -24 | -23 | -23 | -22 | -30 | -39 | -44 | -50 | -52 | -54 |
| Change (%) | 19.95 | 35.68 | 26.30 | -3.56 | -3.69 | -9.00 | -9.89 | 36.54 | 26.76 | -2.62 | -2.69 | -3.22 | -3.33 | 38.63 | 27.86 | 14.49 | 12.65 | 3.51 | 3.39 | |
| % of Revenue | -380.95 | -456.94 | -543.05 | -610.16 | -297.96 | -192.12 | -126.27 | -89.05 | -131.96 | -182.88 | -164.21 | -148.24 | -122.42 | -103.20 | -140.36 | -176.15 | -189.11 | -200.55 | -213.98 | -228.26 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Change (%) | -3.94 | -1.07 | -1.08 | -16.71 | -20.07 | 13.06 | 11.55 | 9.43 | 8.62 | -14.78 | -17.35 | 44.53 | 30.81 | -2.31 | -2.37 | -8.44 | -9.22 | 26.07 | 20.68 | |
| % of Revenue | -1.72 | -1.66 | -1.43 | -1.26 | -0.53 | -0.28 | -0.23 | -0.20 | -0.24 | -0.29 | -0.23 | -0.17 | -0.21 | -0.24 | -0.23 | -0.22 | -0.19 | -0.16 | -0.21 | -0.26 |
| Net Income | -9 | -12 | -15 | -18 | -17 | -17 | -15 | -14 | -19 | -24 | -23 | -23 | -22 | -22 | -30 | -38 | -43 | -48 | -49 | -50 |
| Change (%) | 27.86 | 23.47 | 19.01 | -2.68 | -2.75 | -8.78 | -9.63 | 35.42 | 26.16 | -1.89 | -1.92 | -2.51 | -2.57 | 37.14 | 27.08 | 13.89 | 12.19 | 2.18 | 2.13 | |
| % of Revenue | -394.73 | -504.70 | -545.86 | -577.93 | -284.80 | -185.43 | -122.17 | -86.41 | -127.00 | -175.17 | -158.46 | -144.18 | -119.94 | -101.90 | -137.11 | -171.02 | -182.64 | -192.90 | -203.18 | -214.11 |
Source: Capital IQ
